[1] Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin

[2] Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins

[3] Community respiratory virus infections in immunocompromised patients with cancer

[4] Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients

[5] Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults

[6] Epidemiology of influenza A virus infection in patients with acute or chronic leukemia